Effect of Ceftobiprole on the Intestinal Human Microflora Following Multiple-dose Administration in Healthy Female and Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Community-acquired pneumonia; Gram-negative infections; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Pharmacodynamics
- Sponsors Basilea Pharmaceutica; Janssen-Cilag
- 27 Jul 2012 Company and lead trial centre added as reported by ClinicalTrials.gov.
- 14 Feb 2012 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 14 Feb 2012 Additional locations (Belgium, Sweden) added as reported by ClinicalTrials.gov.